Informação sobre produto
- 7,9-Dihydro-1H-Purine-2,6,8(3H)-trione-13C3
- 1H-Purine-2,6,8-triol-13C3
- 2,6,8-Trihydroxypurine-13C3
- 2,6,8-Trioxopurine-13C3
- 2,6,8-Trioxypurine-13C3
- Lithic Acid-13C3
- NSC 3975-13C3
- Purine-2,6,8(1H,3H,9H)-trione-13C3
- 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-
- 1H-Purine-2,6,8-triol
- Ver mais sinónimos
- 2,3,6,7,8,9-Hexahydro-1H-purine-2,6,8-trione
- 2,6,8-Trihydroxypurine
- 2,6,8-Trioxopurine
- 2,6,8-Trioxypurine
- 6,8(3H)-trione,7,9-dihydro-1H-Purine-2
- 7,9-Dihydro-1H-purine-2,6,8(3H)-trione
- 8(3H)-Trione,7,9-Dihydro-1H-Purine-6
- Acide urique
- Acido Urico
- Harnsaure
- Lithic acid
- Nsc 3975
- Purine-2,6,8(1H,3H,9H)-trione
- Purine-3,6,8(1H,3H,9H)-trione
- Uric acid hyperuricemia
- Uric acid
Applications Isotope labelled Uric Acid is a heterocyclcic compound that is created when purine nucleotides are broken down of by the human body. High blood concetration of Uric Acid is known as hyperuricemia and is often associated with a wide range of disorders and medical conditions such as gout, diabetes and metabolic syndrome. Uric acid may be a marker of oxidative stress and may have a potential therapeutic role as an antioxidant.
References Heinig, M. et al.: Cle. Clin. J. Med., 73, 1059 (2006); Glantzounis, G.K. et al.: Curr. Pharmac. Des., 11, 4145 (2005); Dehghan, A. et al.: Diab. Care, 31, 361 (2008); Nakagawa, T. et al.: Am. J. Physiol. Renal Physiol., 290, F625 (2006);
Propriedades químicas
Consulta técnica sobre: TR-U829204 Uric Acid-13C3
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.